0001415889-21-000527.txt : 20210203 0001415889-21-000527.hdr.sgml : 20210203 20210203191054 ACCESSION NUMBER: 0001415889-21-000527 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chapman Steven Leonard CENTRAL INDEX KEY: 0001711968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 21588046 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 form4-02032021_040235.xml X0306 4 2021-02-01 0001604821 Natera, Inc. NTRA 0001711968 Chapman Steven Leonard C/O NATERA, INC. 201 INDUSTRIAL RD SUITE 410 SAN CARLOS CA 94070 true true false false CHIEF EXECUTIVE OFFICER Common Stock 2021-02-01 4 M 0 525 10.41 A 37689 D Common Stock 2021-02-01 4 M 0 198 10.73 A 37887 D Common Stock 2021-02-01 4 M 0 443 9.29 A 38330 D Common Stock 2021-02-01 4 M 0 281 13.01 A 38611 D Common Stock 2021-02-01 4 M 0 1688 13.01 A 40299 D Common Stock 2021-02-01 4 M 0 490 20.27 A 40789 D Common Stock 2021-02-01 4 M 0 215 25.46 A 41004 D Common Stock 2021-02-01 4 S 0 1926 107.6985 D 39078 D Common Stock 2021-02-01 4 S 0 1914 108.5433 D 37164 D Stock Option (right to buy) 10.41 2021-02-01 4 M 0 525 0 D 2027-06-08 Common Stock 525 9194 D Stock Option (right to buy) 10.73 2021-02-01 4 M 0 198 0 D 2027-07-13 Common Stock 198 3865 D Stock Option (right to buy) 9.29 2021-02-01 4 M 0 443 0 D 2028-03-08 Common Stock 443 46718 D Stock Option (right to buy) 13.01 2021-02-01 4 M 0 281 0 D 2029-01-10 Common Stock 281 52531 D Stock Option (right to buy) 13.01 2021-02-01 4 M 0 1688 0 D 2029-01-10 Common Stock 1688 77687 D Stock Option (right to buy) 20.27 2021-02-01 4 M 0 490 0 D 2029-04-11 Common Stock 490 58572 D Stock Option (right to buy) 25.46 2021-02-01 4 M 0 215 0 D 2030-03-26 Common Stock 215 39431 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.40 to $108.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.05 to $108.82 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of December 18, 2020, the Company's Board of Directors determined the performance criteria had been met with respect to 18,750 additional shares. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Directors determined the performance criteria had been met with respect to 37,500 shares. /s/ Tami Chen, Attorney-in-Fact 2021-02-03